Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-01-07 @ 9:57 AM
Study NCT ID:
NCT02431767
Status:
COMPLETED
Last Update Posted:
2021-10-15
First Post:
2015-04-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2017-06-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-28
First Submit QC Date:
None
Study First Post Date:
2015-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-13
Last Update Post Date:
2021-10-15
Last Update Post Date Type:
ACTUAL